Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003622 |
---|---|
Receipt number | R000004389 |
Scientific Title | A phase II study of nedaplatin plus irinotecan for stage III/IV and EGFR mutation negative non-small cell lung cancer with high-risk factors |
Date of disclosure of the study information | 2010/05/18 |
Last modified on | 2015/01/07 16:02:06 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/05/16 23:54:43 | ||
2 | Update | 2010/11/17 16:40:33 | Email1 |
|
3 | Update | 2010/11/17 16:46:06 | Recruitment status |
|
4 | Update | 2011/07/26 17:09:41 | Recruitment status |
|
5 | Update | 2011/10/06 08:58:03 | Recruitment status |
|
6 | Update | 2012/11/21 09:20:25 | Recruitment status |
|
7 | Update | 2013/01/07 16:42:27 | Recruitment status |
|
8 | Update | 2015/01/07 16:02:06 | Recruitment status |